MOXATAG Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Moxatag, and when can generic versions of Moxatag launch?
Moxatag is a drug marketed by Pragma and is included in one NDA. There are three patents protecting this drug.
This drug has eleven patent family members in six countries.
The generic ingredient in MOXATAG is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Moxatag
A generic version of MOXATAG was approved as amoxicillin by TEVA on December 22nd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MOXATAG?
- What are the global sales for MOXATAG?
- What is Average Wholesale Price for MOXATAG?
Summary for MOXATAG
| International Patents: | 11 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,655 |
| Drug Prices: | Drug price information for MOXATAG |
| DailyMed Link: | MOXATAG at DailyMed |
Recent Clinical Trials for MOXATAG
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nationwide Children's Hospital | N/A |
US Patents and Regulatory Information for MOXATAG
MOXATAG is protected by three US patents.
Patents protecting MOXATAG
Pharmaceutical compositions and methods for improved bacterial eradication
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES
Compositions and methods for improved efficacy of penicillin-type antibiotics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Modified release amoxicillin products
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MOXATAG
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MOXATAG
See the table below for patents covering MOXATAG around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| European Patent Office | 1257255 | ⤷ Sign Up | |
| European Patent Office | 1465591 | ⤷ Sign Up | |
| Japan | 2005538121 | ⤷ Sign Up | |
| Japan | 5377465 | ⤷ Sign Up | |
| World Intellectual Property Organization (WIPO) | 2004012509 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
